KarenHAlbrittonMD

Oncology • Fort Worth, TX

Hematologic Oncology, Sarcoma

Director, Adolescent and Young Adult Oncology, Cook Children's Medical Center. Chairperson, Fort Worth Adolescent and Young Adult Oncology Coalition. Associate Professor, Pediatrics, University of North Texas Health Science Center.

Join to view full profile

Dr. Albritton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Albritton's full profile

Already have an account?

Office
1500 Cooper St
Fort Worth, TX 76104
Phone+1 682-885-4007

Fax+1 682-885-4004

Education & Training

University of North Carolina HospitalsFellowship, Pediatric Hematology/Oncology, 1996 - 2000
University of North Carolina HospitalsResidency, Internal Medicine/Pediatrics, 1992 - 1996
The University of Texas Health Science Center at San AntonioClass of 1992

Certifications & Licensure

TX State Medical License 2010 - 2025
MA State Medical License 2004 - 2011
UT State Medical License 2000 - 2006
NC State Medical License 1992 - 2000

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Boston Magazine Castle Connolly, 2008

Clinical Trials

S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor Start of enrollment: 2003 Dec 01
Completed
Phase 2
Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma Start of enrollment: 2005 Jul 01
Completed
Phase 2
Sperm Banking Among Adolescents Newly Diagnosed With Cancer: Development of a Profiling and Referral Tool Start of enrollment: 2010 Jul 01
Completed
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor Start of enrollment: 2020 Jan 22
Active, not recruiting
Phase 1, Phase 2
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma Start of enrollment: 2020 Mar 04
Terminated
Phase 1, Phase 2
Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease Start of enrollment: 2024 Mar 13
Recruiting
Phase 1, Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Utilization of the Adolescent and Young Adult Psycho-Oncology Screening Tool in a Pediatric Hospital Adolescent/Young Adult Program.
Daniel Elledge, Antonia Leavitt, Alice Hoeft, Karen Albritton
Journal of Adolescent and Young Adult Oncology. 2024-12-01
1 citations
A Comprehensive Clinicopathologic and Molecular Reappraisal of GLI1 -altered Mesenchymal Tumors with Pooled Outcome Analysis Showing Poor Survival in GLI1 - amplified ...
Carla Saoud, Abbas Agaimy, Josephine K Dermawan, Jie-Fu Chen, Marc K Rosenblum
The American Journal of Surgical Pathology. 2024-10-01
Rare case of chronic lymphocytic leukemia in an adolescent treated with targeted therapy.
Ariel Nash, William Weirda, Karen Albritton, Branko Cuglievan, Miriam Garcia
Pediatric Blood & Cancer. 2024-09-01

Press Mentions

A Growing Identity for Adolescent & Young Adult OncologyNovember 10th, 2016